With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention. Helen Coffey speaks to the dentists warning that jabs could have a worrying im ...

With anti-obesity injections dominating conversations, it's no surprise the conversation around their impact is growing. A ...

Solving one of the oldest algebra problems isn't a bad claim to fame, and it's a claim Norman Wildberger can now make: The ...

With pharmaceutical GLP-1 drugs like semaglutide in high demand, Metamorphx offers a plant-based alternative designed to ...

Semaglutide - the active ingredient in medications like Ozempic and WeGovy - is only FDA approved for Type-2 diabetes, but ...

It’s a condition that’s been around as long as humans have been hirsute, but thinning hair has been making headlines over the past year, thanks to the global increase in the use of GLP-1 weight loss ...

Amanda Rodriguez felt exceptionally proud as she ran the Chicago Marathon last fall. She also felt a touch weighed down. With other races on the horizon, she decided to go back on tirzepatide ...

In a world flooded with quick-fix diets, unsafe pills, and unrealistic workout programs, SlimJaro emerges as a reliable, natural, and smart alternative. SlimJaro is a premium, adv ...

Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why NVO stock is a hold.

Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a cultural and medical shift. Its off-label use, fueled by celebrity ...

"an unknown energy source had instantaneously altered the soldiers’ biological structure, transforming them into a substance with the same molecular composition as limestone." After reading the ...

Novo Nordisk is accused in a suit of failing to warn that weight loss drug Ozempic could cause blindness. The plaintiff, a Maryland man, claims he developed non-arteritic anterior ischemic optic ...